eSource

R&D

Capturing data digitally at source can significantly reduce the workflow for sites, yet, implementing it across studies has been rather unattainable.

News

argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.